Karuna Therapeutics Inc. (KRTX) PT Raised to $131 at Goldman Sachs
Tweet
Share
E-mailGet Alerts KRTX Hot Sheet
Price: $329.83 --0%
Rating Summary:
8 Buy, 16 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
8 Buy, 16 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Goldman Sachs analyst Salveen Richter raised the price target on Karuna Therapeutics Inc. (NASDAQ: KRTX) to $131.00 (from $115.00) while maintaining a Buy rating.
You May Also Be Interested In
- Citi Downgrades Lend Lease Group (LLC:AU) (LLESY) to Neutral
- Citi Downgrades JB Hi-Fi Ltd (JBH:AU) to Neutral
- Greatland Resources Ltd (GGP:AU) PT Lowered to AUD14 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
